Neurol. praxi. 2008;9(4):245-251

Léčba diabetické polyneuropatie

MUDr. Helena Vondrová, CSc.
Neurologická klinika FTN, Praha

Léčba DN by měla být vždy komplexní. Lze ji rozdělit na všeobecná a specifická opatření. Hlavní důraz spočívá na zajištění co nejdokonalejší kompenzace diabetu. Specifické postupy zahrnují léčbu symptomatickou, paliativní a podpůrnou a směřují především k odstranění subjektivních obtíží. Léčba, vycházející ze znalostí etiopatogenezy DN, nenalezla dosud výraznějšího uplatnění.

Keywords: Klíčová slova: kompenzace diabetu, etiopatogenetická léčba, antidepresiva, antikonvulziva.

Published: November 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vondrová H. Léčba diabetické polyneuropatie. Neurol. praxi. 2008;9(4):245-251.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ambler Z, Bednařík J, Keller O. Doporučený postup pro léčbu neuropatické bolesti. Čes Slov Neurol Neurochir 2002; 3: 135-138.
    2. Bakker SJL, Heine RJ, Gans ROB. Thiamine may indirectly act as an antioxidant. Diabetologia, 1997; 40: 741-742.
    3. Benbow SJ, Daousi C, MacFarlane IA. Painful diabetic neuropaty. In: Diabetes. Best Praktice Research Kompendium. Edited by Antony H. Barnett, Elsevier 2006: 127-136.
    4. Bloomgarden ZT. Diabetic Neuropathy. Diabetes Care, Vol. 31, No 3, March 2008. Go to original source... Go to PubMed...
    5. Boulton AJM, Vinik AI, Arezzo JC, et al. Diabetic Neuropathies. Diabetes Care 28: 956-962, 2005. Go to original source... Go to PubMed...
    6. Brownlee M, Lloyd PA, Cooper ME, Vinik AJ, Nesto RW, Boulton JM. Complication of Diabetes Mellitus. In Kronenberg HM, Melhep S, Polonsky KS, Larsen PR. Williams Textbook of Endocrinology. Edition 11. Saunders Elsevier 2008: 1453-1469.
    7. Cordonnier DJ, Zaoui P, Halimi S. Role of ACE inhibitors in patients with diabetes mellitus. Drugs 2001, 61, No 13, p. 1883-1892. Go to original source... Go to PubMed...
    8. Diabetes Control and Complications Trial Research Group: The effect of intensive Treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 1993, 329, No 14, p. 977-986. Go to original source... Go to PubMed...
    9. Diabetes Control and Complications trial (DCCT) Research Group: Effect of Intensive Diabetes Treatment on Nerve Conduction in the Diabetes Control and Complications Trial. Ann Neurol 1995; 38, 6: 869-880. Go to original source... Go to PubMed...
    10. Dukes E, Gore, M, Leslie D. Clinical characteristic and pain management in patients with painful diabetic neuropathy (PDN) in general practice settings in the United Kingdom. Diabetologia 2005; 48, Suppl 1, A350.
    11. Hotta N, Akanuma Y, Kawamori R,Matsuoka K, Oka Y, Shichiri M, Toyota T, Nakashima M, Yoshimura I, Sakamoto N, Shigeta Y. Long-term clinical effects of epalrestat, an aldose reduktase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reduktase Inhibitor-Diabetes Complications Trial. Diabetes Care 2006; Jul 29(7): 1538-1544. Go to original source... Go to PubMed...
    12. Chong MS, Hester J. Diabetic Painful Neuropaty. Current and Future Treatment Options. Drugs 2007; 67(4): 569-585. Go to original source... Go to PubMed...
    13. Kožnarová R, Saudek F, Sosna T, Vondrová H. Průběh pozdních komplikací diabetu po úspěšné kombinované transplantaci ledviny a pankreatu - výsledek 5letého sledování. V. konference Transplantace orgánů a tkání Brno 2002. Sborník abstrakt 2002: 26.
    14. Opavský J. Autonomní nervový systém a diabetická autonomní neuropatie. Praha: Galén 2002.
    15. Sawynok J, Esser MJ, Reid AR. Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci 2001; 26, 1: 21-29.
    16. Standardy péče o diabetes mellitus. www.diab.cz.
    17. Tesfaye S. Diabetic Neuropathy. In: Wass JAH, et al. Oxford Textbook of Endocrinology and Diabetes. 2002: 1789-1798.
    18. Tesfay S, Tandan R, Bastyr EJ, Kles KA, Skijarevski V, Price KL. Factors That Impact Symptomatic Diabetic Peripheral Neuropaty in Placebo-Administered Patiens From Two 1-Year Clinical trials. Diabetes Care 2007; 30, 10: 2626-2632. Go to original source... Go to PubMed...
    19. Thornalley PJ. Glycation in diabetic neuropathy: characteristics, consequences, cause, and therapeutic options. Int Rev Neurobiol. 2002; 50: 37-57. Go to original source... Go to PubMed...
    20. UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853. Go to original source...
    21. Vaillancourt PD, Langevin HM: Painful Peripheral Neuropathies. Med. Clin. North Am 1999; 83, 3: 627-642. Go to original source... Go to PubMed...
    22. Vileikyte L, Leventhal H, Gonzales JS. Diabetic Peripheral Neuropathy and Depressive Symptomas. Diabetes Care, 2005, Vol. 28, No 10, p. 2378-2383. Go to original source... Go to PubMed...
    23. Vinik AI. CLINICAL REVIEW: Use of Antiepileptic Drugs in the Treatment of Chronic Painful Diabetic Neuropathy. J Clin Endocrinol Metab 2005, Vol. 90, No 8, p. 4936-4945. Go to original source... Go to PubMed...
    24. Vinik AI, Pittenger GL, Barlow P. Mehrabyan A. Diabetic Neuropathies.In: LeRoith D, Taylor SI, Olefsky JM. Diabetes Mellitus 3rd Edition Lippincott Williams Wilkins 2004: 1331-1364.
    25. Ziegler D, Hanefeld M, Ruhnau KJ, Hasche H, Lobisch M, Schutte K, Kerum G, Malessa R. The ALADIN III Study Group: Treatment of Symptomatic Diabetic Polyneuropathy With the Antioxidant Alfa-Lipoic Acid. Diabetes Care 1999; 22, 8: 1296-1301. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.